The evaluation of hormone receptor (HR) status, specifically estrogen receptor (ER) and progesterone receptor (PgR), along with HER2 status, constitutes another essential aspect of BC profiling [17,18,19]. The gene discussed is NR4A1; the disease is breast cancer.